Phospholipase A2 Metabolites Regulate Inducible Nitric Oxide Synthase in Myocytes

Hypertension

Volumn 31, Issue 1, 1998, Pages 218-224

  LaPointe, Margot C ^a   Sitkins, Jodi R ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 AMYLCINNAMIDO) 4 CHLOROBENZOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; LIPOXYGENASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; ISOENZYME; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; PHOSPHOLIPASE A; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; HEART FAILURE; HEART MUSCLE CELL; INFLAMMATION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TISSUE INJURY; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENETIC TRANSCRIPTION; HEART MUSCLE; METABOLISM; SPRAGUE DAWLEY RAT;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; EPOPROSTENOL; INDOMETHACIN; INTERLEUKIN-1; ISOENZYMES; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 0031600628     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.218     Document Type: Article

References (54)

1. Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CRF. Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. Mol Endocrinol. 1992;6:1921-1930.
2. Balligand J-L, Ungureanu-Longrois D, Simons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 1994;269:27580-27588.
3. Harding P, Carretero OA, LaPointe MC. Effects of interleukin-1 beta and nitric oxide on cardiac myocytes. Hypertension. 1995;25:421-430.
4. LaPointe MC, Sitkins JR. Mechanisms of interleukin-1 beta regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 1996;27:709-714.
5. Dudek RR, Wildhirt S, Pinto V, Giesler G, Bing RJ. Dexamethasone inhibits the expression of an inducible nitric oxide synthase in infarcted rabbit myocardium. Biochem Biophys Res Commun. 1994;202:1120-1126.
6. Yang X, Chowdhury N, Cai B, Brett J, Marboe C, Sciacca RR, Michler RE, Cannon PJ. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest. 1994;94:714-721.
7. Worrall NK, Lazenby WD, Misko TP, Lin T-S, Rodi CP, Manning PT, Tilton RG, Williamson JR, Ferguson TB. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med. 1995;181:63-70.
8. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087-1094.
9. Appleton I, Tomlinson A, Willoughby DA. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv Pharmacol. 1996;35:27-78.
10. 2 -dependent signalling in the heart. Cardiovasc Res. 1995;30:518-529.
11. Nasjletti A, McGiff JC. Prostaglandins. In: Izzo JL, Black HR, eds. Hypertension Primer. Dallas: American Heart Association; 1993:23-25.
12. Nadler JL. Lipoxygenase products. In: Izzo JL, Black HR, eds. Hypertension Primer. Dallas: American Heart Association; 1993:25-26.
13. Chiariello M, Ambrosio G, Cappelli-Bigazzi M, Nevola E, Perrone-Filardi P, Maone G, Condorelli M. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. J Pharmacol Exp Ther. 1987;241:560-568.
14. 2 and C in myocardial ischemic reperfusion injury. Am J Physiol. 1991;260:H877-H883.
15. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993;90:7240-7244.
16. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A. 1994;91:12168-12172.
17. Corbett JA, Kwon G, Turk J, McDaniel ML. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry. 1993;32:13767-13770.
18. 2 production by vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;194:420-424.
19. 2 pathways in pregnant rat uteri. Am J Physiol. 1996;270:E471-E476.
20. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res. 1996;78:759-768.
21. Amin AR, Attur M, Patel RN, Tahkker GD, Marshall PJ, Rediske J, Stuchin SA, Patel Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide. J Clin Invest. 1997;99:1231-1237.
22. LaPointe MC, Sitkins JR. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide (BNP) from cultured neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor (ANF). Mol Endocrinol. 1993;7:1284-1296.
23. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol. 1988;141:2407-2412.
24. Hinterleitner TA, Saada JI, Berschneider HM, Powell DW, Valentich JD. IL-1 stimulates intestinal myofibroblast COX gene expression and augments activation of Cl secretion in T84 cells. Am J Physiol. 1996;271:C1262-C1268.
25. 2. Exp Cell Res. 1993;206:58-62.
26. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by IL-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 1995;95:1669-1675.
27. Rzymkiewicz DM, DuMaine J, Morrison AR. IL-1 beta regulates rat mesangial cyclooxygenase II gene expression by tyrosine phosphorylation. Kidney Int. 1995;47:1354-1363.
28. 2. J Biol Chem. 1994;269:13057-13060.
29. 2. J Biol Chem. 1997;272:16069-16072.
30. Srivastava SK, Tetsuka T, Daphna-Iken D, Morrison AR. IL-1 beta stabilizes COX-2 mRNA in renal mesangial cells: role of 3'-untranslated region. Am J Physiol. 1994;267:F504-F508.
31. Panara MR, Greco A, Santini G, Sciulli MG, Rotondo MT, Padovano R, di Giamberardino M, Cipollone F, Cuccurullo F, Patrono C, Patrignani P. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. Br J Pharmacol. 1995;116:2429-2434.
32. Oudot F, Grynberg A, Sergiel JP. Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids. Am J Physiol. 1995;268:H308-H315.
33. Engels W, Van Bilsen M, De Groot MJM, Lemmens PJMR, Willemsen PHM, Reneman RS, Van der Vusse GJ. Ischemia and reperfusion induced formation of eicosanoids in isolated rat hearts. Am J Physiol. 1990;258:H1865-H1871.
34. 2 gene family in mammals. J Biol Chem. 1997;272:17247-17250.
35. 2. J Biol Chem. 1997;272:16709-16712.
36. 2. J Biol Chem. 1991;266:14119-14127.
37. 2 synthesis in rabbit articular chondrocytes. Biochem Biophys Res Commun. 1989;164:488-495.
38. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991;266:2647-2651.
39. 1 macrophages. J Biol Chem. 1996;271:6758-6765.
40. Rizzo MT, Boswell HS, Mangoni L, Carlo-Stella C, Rizzoli V. Arachidonic acid induces c-jun expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-alpha: evidence for a tyrosine kinase-dependent process. Blood. 1995;86:2967-2975.
41. Rizzo MT, Carlo-Stella C. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino terminal kinase in stromal cells. Blood. 1996;88:3792-3800.
42. Cui X-L, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci U S A. 1997;94:3771-3776.
43. 2 -terminal kinase). Eur J Biochem. 1997;244:587-595.
44. Exton JH. Phospholipase D. enzymology, mechanisms of regulation, and function. Physiol Revs. 1997;77:303-320.
45. Massey CV, Kohout TA, Gaa ST, Lederer WJ, Rogers TB. Molecular and cellular actions of platelet-activating factor in rat heart cells. J Clin Invest. 1991;88:2106-2116.
46. Pavani M, Fones E, Oksenberg D, Garcia M, Hernandez C, Cordano G, Munoz S, Mancoilla J, Guerrero A, Ferreira J. Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid. Biochem Pharmacol. 1994;48:1935-1942.
47. LaPointe MC. Redox regulation of inducible nitric oxide synthase in neonatal ventricular myocytes. Circulation 1995;92(suppl.):I-347. Abstract.
48. O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, Daniel LW. 5-oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway. J Biol Chem. 1996;271:17821-17828.
49. Rao GN, Glasgow WC, Eling TE, Runge MS. Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein (AP-1) activity. J Biol Chem. 1996;271:27760-27764.
50. Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, Chiarpotto E, Baeuerle PA, Poli G. Nuclear factor kappa B is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun. 1996;229:643-647.
51. Lee S, Felts KA, Parry GCN, Armacost LM, Cobb RR. Inhibition of 5-lipoxygenase blocks IL-1 beta-induced vascular adhesion molecule-1 gene expression in human endothelial cells. J Immunol. 1997;158:3401-3407.
52. LaPointe MC. Mechanisms of interleukin-1 beta regulation of inducible nitric oxide synthase in ventricular myocytes. Hypertension. 1995;26:549. Abstract.
53. Xie Q-W, Kashiwabara Y, Nathan C. Role of transcription factor NF kappa B/rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708.
54. Lepley RA, Muskardin DT, Fitzpatrick FA. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J Biol Chem. 1996;271:6179-6184.